Point72 Hong Kong’s Vaxcyte PCVX Stock Holding History

Point72 Hong Kong’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-7,716	Closed	-$244K	–	1439
2020 Q2	$244K	Buy	+7,716	New	+$248K	0.03%	481

Other funds holding PCVX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

MVM

Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Hong Kong's PCVX Position: Q3 2020 in Review

Point72 Hong Kong sold out of Vaxcyte (PCVX) in Q3 2020, closing a stake of 7,716 shares — an estimated $244K sold.

Point72 Hong Kong first reported a position in PCVX in Q2 2020 and held it in 1 quarter. The position peaked at $244K in Q2 2020. 60 funds tracked by Wall St. Rank hold PCVX as of Q3 2020.

Point72 Hong Kong reported no remaining Vaxcyte position as of Q3 2020 after selling out during the quarter.
Point72 Hong Kong sold 7,716 Vaxcyte shares in Q3 2020, an estimated $244K.
Point72 Hong Kong first reported a position in Vaxcyte in Q2 2020 and held it in 1 quarter.
Point72 Hong Kong's Vaxcyte position peaked at $244K in Q2 2020.
60 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2020.

Based on Point72 Hong Kong's 13F filing for Q3 2020, filed 16 Nov 2020.